← Back to Search

Amoxicillin for Penicillin Allergy

Phase 4
Waitlist Available
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10-14 months after amoxicillin challenge
Awards & highlights

Study Summary

This trial is looking at the feasibility of delabeling patients who have a reported penicillin allergy in a pediatric primary care clinic.

Eligible Conditions
  • Penicillin Allergy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10-14 months after amoxicillin challenge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10-14 months after amoxicillin challenge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Subjects stratified as low-risk with a negative immediate amoxicillin challenge in the pediatric primary care setting
Subjects who complete risk-stratification of penicillin allergy in the pediatric primary care setting
Secondary outcome measures
Penicillin allergy labeling in subjects with negative amoxicillin challenge

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pediatric Patients with a history of penicillin allergyExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Amoxicillin
2017
Completed Phase 4
~7780

Find a Location

Who is running the clinical trial?

American College of Allergy, Asthma and ImmunologyOTHER
3 Previous Clinical Trials
31 Total Patients Enrolled
University of Texas Southwestern Medical CenterLead Sponsor
1,055 Previous Clinical Trials
1,054,846 Total Patients Enrolled

Media Library

Amoxicillin Clinical Trial Eligibility Overview. Trial Name: NCT05010304 — Phase 4
Penicillin Allergy Research Study Groups: Pediatric Patients with a history of penicillin allergy
Penicillin Allergy Clinical Trial 2023: Amoxicillin Highlights & Side Effects. Trial Name: NCT05010304 — Phase 4
Amoxicillin 2023 Treatment Timeline for Medical Study. Trial Name: NCT05010304 — Phase 4
~7 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top